Oral treatment with the novel fatty acid synthase inhibitor denifanstat induced significant improvements in ...
Sagimet Biosciences Inc. (NASDAQ:SGMT) said on Wednesday that denifanstat met all primary and secondary endpoints in a Phase 3 trial for moderate to severe acne vulgaris. The trial was conducted by ...
Two teens who previously used antibiotic topical acne gels experienced anaphylaxis following administration of IV clindamycin prior to third-molar surgeries, according to a case report published in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback